Sort   by:  
 Page size 
UnknownDevelopment of the Nova Scotia Potential Donor Audit (PDA) Tool and 2020 Historic Performance Database: Lessons Learned From the First 1000 Medical Record Reviews.
Not available
S-EPMC10593262 | biostudies-literature
UnknownLedipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.
Not available
S-EPMC4892372 | biostudies-literature
UnknownIdentification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study.
Not available
S-EPMC3014359 | biostudies-literature
UnknownAssociation of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus.
Not available
S-EPMC3103780 | biostudies-literature
UnknownIdentification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study.
Not available
S-EPMC3322228 | biostudies-literature
UnknownComparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257.
Not available
S-EPMC4660025 | biostudies-literature
UnknownEvaluation of TRAF6 in a large multiancestral lupus cohort.
Not available
S-EPMC3380425 | biostudies-literature
UnknownThe major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
Not available
S-EPMC3235490 | biostudies-literature
UnknownEffect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
Not available
S-EPMC8491132 | biostudies-literature
Sort   by:  
 Page size